Financhill
Sell
47

NICE Quote, Financials, Valuation and Earnings

Last price:
$165.89
Seasonality move :
4.15%
Day range:
$162.90 - $166.90
52-week range:
$137.19 - $200.65
Dividend yield:
0%
P/E ratio:
23.14x
P/S ratio:
3.88x
P/B ratio:
3.00x
Volume:
314.3K
Avg. volume:
385.4K
1-year change:
-11.02%
Market cap:
$10.5B
Revenue:
$2.7B
EPS (TTM):
$7.17

Earnings Data

Next earnings date for NICE
Aug 15
2025
Most recent earnings per share
$2.01
Missed by $0.83
(May 15/2025)
Consensus Estimate
$2.84
(May 15/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NICE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/15/2025 Q2 $713.2M -- -- $2.99 --
05/15/2025 Q1 $699.4M $700.2M $2.01 $2.84 -$0.83
02/20/2025 Q4 $714.9M $721.6M $1.54 $2.95 -$1.41
11/14/2024 Q3 $683M $690M $1.86 $2.68 -$0.82
08/15/2024 Q2 $663.3M $664.4M $1.76 $2.58 -$0.82
05/16/2024 Q1 $655.4M $659.3M $1.60 $2.45 -$0.85
02/22/2024 Q4 $617.2M $623.2M $1.24 $2.26 -$1.02
11/16/2023 Q3 -- -- $1.39 $2.15 -$0.76
08/17/2023 Q2 -- -- $1.31 $2.06 -$0.75
05/11/2023 Q1 -- -- $1.15 $1.98 -$0.83
02/23/2023 Q4 -- -- $1.07 $1.93 -$0.86
11/10/2022 Q3 -- -- $1.07 $1.87 -$0.80
08/18/2022 Q2 -- -- $0.99 $1.79 -$0.80
05/12/2022 Q1 -- -- $0.87 $1.71 -$0.84
02/17/2022 Q4 -- -- $0.76 $1.71 -$0.95
11/11/2021 Q3 -- -- $0.70 $1.58 -$0.88
08/05/2021 Q2 -- -- $0.67 $1.51 -$0.84
05/13/2021 Q1 -- -- $0.78 $1.50 -$0.72
02/18/2021 Q4 -- -- $0.83 $1.56 -$0.73
11/12/2020 Q3 -- -- $0.76 $1.39 -$0.63
08/06/2020 Q2 -- -- $0.68 $1.32 -$0.64
05/14/2020 Q1 -- -- $0.71 $1.32 -$0.61
02/13/2020 Q4 -- -- $0.95 $1.53 -$0.58
11/14/2019 Q3 -- -- $0.69 $1.28 -$0.59
08/08/2019 Q2 -- -- $1.25 $1.22 $0.03
05/16/2019 Q1 -- -- $1.18 $1.11 $0.07
02/14/2019 Q4 -- -- $1.47 $1.41 $0.06
11/08/2018 Q3 -- -- $1.12 $1.07 $0.05
08/09/2018 Q2 -- -- $1.06 $1.02 $0.04
05/10/2018 Q1 -- -- $1.03 $1.01 $0.02
02/15/2018 Q4 -- -- $1.35 $1.32 $0.03
11/02/2017 Q3 -- -- $0.95 $0.93 $0.02
08/03/2017 Q2 -- -- $0.90 $0.87 $0.03
05/04/2017 Q1 -- -- $0.89 $0.84 $0.05
02/16/2017 Q4 -- -- $1.18 $1.18 $0.00
11/10/2016 Q3 -- -- $0.72 $0.68 $0.04
07/28/2016 Q2 -- -- $0.68 $0.67 $0.01
05/05/2016 Q1 -- -- $0.73 $0.64 $0.09
02/11/2016 Q4 -- -- $1.01 $0.94 $0.07
10/29/2015 Q3 -- -- $0.68 $0.58 $0.10
07/30/2015 Q2 -- -- $0.62 $0.57 $0.05

NICE Earnings Questions

  • How Much did NICE Generate in Revenue Last Quarter?

    NICE reported $700.2M worth of top line sales in its most recent quarter.

  • Did NICE Beat Earnings Last Quarter?

    NICE announced earnings per share of $2.01 which represents a miss of analyst forecast a $2.84 per share.

  • Is NICE Profitable?

    NICE reported $468.1M that represents $7.27 per share over the last quarter.

  • What is the Analyst Consensus for NICE EPS Next Year?

    NICE's earnings are forecast to grow from $6.76 per share to $11.05 per share next year representing an increase of 82.96%.

  • When is NICE's Earnings Date?

    NICE's next earnings date is August 15, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Salesforce Stock Be in 5 Years?
Where Will Salesforce Stock Be in 5 Years?

Salesforce (NYSE: CRM) just turned in a quarter that, on…

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock